AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
96,100
Employees96,100
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1913
Founded1913
Employees
96,100
Employees96,100

AZN Key Statistics

Market cap
290.13B
Market cap290.13B
Price-Earnings ratio
27.91
Price-Earnings ratio27.91
Dividend yield
1.68%
Dividend yield1.68%
Average volume
1.68M
Average volume1.68M
High today
$189.08
High today$189.08
Low today
$186.49
Low today$186.49
Open price
$188.22
Open price$188.22
Volume
1.61M
Volume1.61M
52 Week high
$212.71
52 Week high$212.71
52 Week low
$137.23
52 Week low$137.23

Stock Snapshot

As of today, AstraZeneca(AZN) shares are valued at $187.03. The company's market cap stands at 290.13B, with a P/E ratio of 27.91 and a dividend yield of 1.7%.

On 2026-05-24, AstraZeneca(AZN) stock moved within a range of $186.49 to $189.08. With shares now at $187.03, the stock is trading +0.3% above its intraday low and -1.1% below the session's peak.

Trading activity shows a volume of 1.61M, compared to an average daily volume of 1.68M.

Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $137.23.

Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $137.23.

AZN News

TipRanks 2d
AstraZeneca Advances First-in-Human AZD8359 Study in Metastatic Prostate Cancer

AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence...

TipRanks 3d
Daiichi Sankyo, AstraZeneca’s Datroway approved in U.S to treat TNBC

Daiichi Sankyo (DSNKY) and AstraZeneca’s (AZN) Datroway has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic triple...

TipRanks 3d
AstraZeneca and Daiichi Sankyo’s Enhertu recommended in EU by CHMP in HER2

The company states: “AstraZeneca (AZN) and Daiichi Sankyo’s (DSNKY) Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union as...

Analyst ratings

83%

of 30 ratings
Buy
83.3%
Hold
10%
Sell
6.7%

More AZN News

TipRanks 3d
AstraZeneca’s Camizestrant recommended for approval in EU by CHMP

The company states: “AstraZeneca’s (AZN) camizestrant in combination with a cyclin-dependent kinase 4/6 inhibitor (palbociclib, ribociclib or abemaciclib) has b...

TipRanks 3d
AstraZeneca announces new data from portfolio, pipeline at ASCO meeting

AstraZeneca (AZN) announces new data across its portfolio and pipeline at the American Society of Clinical Oncology, ASCO, Annual Meeting, 29 May to 2 June 2026...

TipRanks 4d
AstraZeneca: Buy Rating Reiterated on Late-Stage Pipeline Upside; Price Target Unchanged at 16,500 GBp

AstraZeneca, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank of America Securities reiterated a Buy r...

TipRanks 5d
AstraZeneca’s Earnings Call Balances Growth and Risk

AstraZeneca plc ((GB:AZN)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and p...

TipRanks 5d
Compugen Earnings Call Highlights Trials, Cash Runway

Compugen ((CGEN)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful i...

Benzinga 6d
AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology Portfolios

AstraZeneca Secures FDA Approval For Baxfendy In Hypertension The company also announced expanded FDA approvals for Enhertu in HER2-positive early breast cance...

AstraZeneca Scores Key FDA Wins Across Cardiovascular And Oncology Portfolios
TipRanks 7d
AstraZeneca CEO Pascal Soriot Receives Vesting of Performance Share Award

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

People also own

Based on the portfolios of people who own AZN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.